References
[1]. Tarantola, A., Four thousand years of concepts relating to rabies in animals and humans, its prevention and its cure. Tropical medicine and infectious disease, 2017. 2(2): p. 5.
[2]. Jiaxi, C., Research Progress of Vaccines and Diagnosis TreatmentMethod in Rabies. 2023-07-20.
[3]. Banyard, A. and N. Tordo, Rabies pathogenesis and immunology. Revue scientifique et technique (International Office of Epizootics), 2018. 37(2): p. 323-330.
[4]. Nigg, A.J. and P.L. Walker, Overview, prevention, and treatment of rabies. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2009. 29(10): p. 1182-1195.
[5]. Willoughby, R.E., A cure for rabies? Scientific American, 2007. 296(4): p. 88-95.
[6]. Mitrabhakdi, E., et al., Difference in neuropathogenetic mechanisms in human furious and paralytic rabies. Journal of the neurological sciences, 2005. 238(1-2): p. 3-10.
[7]. Hemachudha, T., et al., Human rabies: neuropathogenesis, diagnosis, and management. The Lancet Neurology, 2013. 12(5): p. 498-513.
[8]. Warrell, D. and M. Warrell, Human rabies and its prevention: an overview. Reviews of infectious diseases, 1988. 10(Supplement_4): p. S726-S731.
[9]. Jiaxin, Y., Can Rabies Be Cured. Scientific American, 2012-5-17.
[10]. McGettigan, J.P., Experimental rabies vaccines for humans. Expert review of vaccines, 2010. 9(10): p. 1177-1186.
[11]. Wu, X., T.G. Smith, and C.E. Rupprecht, From brain passage to cell adaptation: the road of human rabies vaccine development. Expert review of vaccines, 2011. 10(11): p. 1597-1608.
[12]. Fermi, C., Über die immunisierung gegen wutkrankheit. Zeitschrift für Hygiene und Infektionskrankheiten, 1908. 58(1): p. 233-276.
[13]. Kissling, R., Growth of rabies virus in non-nervous tissue culture. Proceedings of the society for experimental biology and medicine, 1958. 98(2): p. 223-225.
[14]. Hooper, D.C., et al., Collaboration of antibody and inflammation in clearance of rabies virus from the central nervous system. Journal of virology, 1998. 72(5): p. 3711-3719.
[15]. Hicks, D., A. Fooks, and N. Johnson, Developments in rabies vaccines. Clinical & Experimental Immunology, 2012. 169(3): p. 199-204.
[16]. Huang, C.T., et al., Enhancement of blood–brain barrier permeability is required for intravenously administered virus neutralizing antibodies to clear an established rabies virus infection from the brain and prevent the development of rabies in mice. Antiviral Research, 2014. 110: p. 132-141.
[17]. Shimao, Z. and G. Caiping, Rabies Control and Treatment: From Prophylaxis to Strategies with Curative Potential. Viruses, 2016. 8(11).
[18]. Li, J., et al., Single domain antibody-based bispecific antibody induces potent specific anti-tumor activity. Cancer Biology & Therapy, 2016: p. 00-00.
[19]. Conceição, P. and C. Abreu, Human rabies: optimization of prevention and paths towards the cure. Acta Medica Portuguesa, vol. 34 (11), p. 767-773, 2020.
Cite this article
Wu,X. (2023). Research on the rabies and rabies vaccines. Theoretical and Natural Science,24,146-150.
Data availability
The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.
Disclaimer/Publisher's Note
The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of EWA Publishing and/or the editor(s). EWA Publishing and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
About volume
Volume title: Proceedings of the 3rd International Conference on Biological Engineering and Medical Science
© 2024 by the author(s). Licensee EWA Publishing, Oxford, UK. This article is an open access article distributed under the terms and
conditions of the Creative Commons Attribution (CC BY) license. Authors who
publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons
Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this
series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published
version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial
publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and
during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See
Open access policy for details).
References
[1]. Tarantola, A., Four thousand years of concepts relating to rabies in animals and humans, its prevention and its cure. Tropical medicine and infectious disease, 2017. 2(2): p. 5.
[2]. Jiaxi, C., Research Progress of Vaccines and Diagnosis TreatmentMethod in Rabies. 2023-07-20.
[3]. Banyard, A. and N. Tordo, Rabies pathogenesis and immunology. Revue scientifique et technique (International Office of Epizootics), 2018. 37(2): p. 323-330.
[4]. Nigg, A.J. and P.L. Walker, Overview, prevention, and treatment of rabies. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2009. 29(10): p. 1182-1195.
[5]. Willoughby, R.E., A cure for rabies? Scientific American, 2007. 296(4): p. 88-95.
[6]. Mitrabhakdi, E., et al., Difference in neuropathogenetic mechanisms in human furious and paralytic rabies. Journal of the neurological sciences, 2005. 238(1-2): p. 3-10.
[7]. Hemachudha, T., et al., Human rabies: neuropathogenesis, diagnosis, and management. The Lancet Neurology, 2013. 12(5): p. 498-513.
[8]. Warrell, D. and M. Warrell, Human rabies and its prevention: an overview. Reviews of infectious diseases, 1988. 10(Supplement_4): p. S726-S731.
[9]. Jiaxin, Y., Can Rabies Be Cured. Scientific American, 2012-5-17.
[10]. McGettigan, J.P., Experimental rabies vaccines for humans. Expert review of vaccines, 2010. 9(10): p. 1177-1186.
[11]. Wu, X., T.G. Smith, and C.E. Rupprecht, From brain passage to cell adaptation: the road of human rabies vaccine development. Expert review of vaccines, 2011. 10(11): p. 1597-1608.
[12]. Fermi, C., Über die immunisierung gegen wutkrankheit. Zeitschrift für Hygiene und Infektionskrankheiten, 1908. 58(1): p. 233-276.
[13]. Kissling, R., Growth of rabies virus in non-nervous tissue culture. Proceedings of the society for experimental biology and medicine, 1958. 98(2): p. 223-225.
[14]. Hooper, D.C., et al., Collaboration of antibody and inflammation in clearance of rabies virus from the central nervous system. Journal of virology, 1998. 72(5): p. 3711-3719.
[15]. Hicks, D., A. Fooks, and N. Johnson, Developments in rabies vaccines. Clinical & Experimental Immunology, 2012. 169(3): p. 199-204.
[16]. Huang, C.T., et al., Enhancement of blood–brain barrier permeability is required for intravenously administered virus neutralizing antibodies to clear an established rabies virus infection from the brain and prevent the development of rabies in mice. Antiviral Research, 2014. 110: p. 132-141.
[17]. Shimao, Z. and G. Caiping, Rabies Control and Treatment: From Prophylaxis to Strategies with Curative Potential. Viruses, 2016. 8(11).
[18]. Li, J., et al., Single domain antibody-based bispecific antibody induces potent specific anti-tumor activity. Cancer Biology & Therapy, 2016: p. 00-00.
[19]. Conceição, P. and C. Abreu, Human rabies: optimization of prevention and paths towards the cure. Acta Medica Portuguesa, vol. 34 (11), p. 767-773, 2020.